Transcranial Magnetic Stimulation Treatment for Smoking Cessation: An Introduction for Primary Care Clinicians

Am J Med. 2021 Nov;134(11):1339-1343. doi: 10.1016/j.amjmed.2021.06.037. Epub 2021 Aug 15.

Abstract

Tobacco use remains the number one preventable cause of death in the United States, resulting in significant public health and economic costs. Despite progress in reducing tobacco use through pharmacotherapy and psychotherapy smoking cessation interventions, additional treatment options are still needed to improve treatment effectiveness. As an adjunctive treatment, the US Food and Drug Administration recently cleared transcranial magnetic stimulation (TMS), a noninvasive brain stimulation technique, as an aid for smoking cessation in adults. Given that most smoking cessation interventions occur in the primary care setting, this article aims to introduce TMS, to provide an overview of the evidence of TMS for smoking cessation, and to outline the procedures for implementing TMS in the primary care setting when referral to an interventional psychiatrist is not possible. With growing scientific evidence and increasing regulatory approval of TMS for smoking cessation, this novel treatment option is now available for patients who want to quit smoking but have been unsuccessful with pharmacologic approaches.

Keywords: Addiction; Smoking cessation; TMS; Tobacco; Transcranial magnetic stimulation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Humans
  • Primary Health Care*
  • Psychotherapy
  • Smoking Cessation / methods*
  • Smoking Cessation Agents / therapeutic use
  • Tobacco Use Disorder / therapy*
  • Transcranial Magnetic Stimulation / methods*

Substances

  • Smoking Cessation Agents